spironolactone has been researched along with finasteride in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (15.69) | 18.2507 |
2000's | 21 (41.18) | 29.6817 |
2010's | 17 (33.33) | 24.3611 |
2020's | 5 (9.80) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chang, L; Lobo, RA; Morris, RS; Spahn, MA; Stanczyk, FZ; Wong, IL | 1 |
Shaw, JC | 1 |
Durmuşoğlu, F; Erenus, M; Gürbüz, O; Yücelten, D | 1 |
Schmidt, JB | 1 |
Price, VH; Shapiro, J | 1 |
Sinclair, R; Young, R | 1 |
Sinclair, RD; Tran, D | 1 |
Rittmaster, RS | 1 |
Castello, R; Dorizzi, R; Fortunato, A; Moghetti, P; Muggeo, M; Negri, C; Spiazzi, GG; Tosi, F | 1 |
Caputo, M; Castello, R; Misciali, C; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Tosti, A | 1 |
Mercurio, MG | 1 |
Canosa, LF; Ceballos, NR | 1 |
Olsen, EA | 1 |
Hannuksela, M | 1 |
Bayram, F; Everest, H; Keleştimur, F; Unlühizarci K, K | 1 |
Lumachi, F; Rondinone, R | 1 |
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
Bayram, F; Everest, H; Keleştimur, F; Sahin, Y; Unlühizarci, K | 1 |
Bandaranayake, I; Mirmirani, P | 1 |
Kelestimur, F; Sahin, Y | 1 |
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA | 1 |
Al-Inany, H | 2 |
Burnham, WM; Edwards, HE; Vimal, S | 1 |
Conway, GS; Koulouri, O | 1 |
Scheinfeld, N | 1 |
Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S | 1 |
Brodell, LA; Mercurio, MG | 1 |
Bell, RR; John-Baptiste, A; Levin, S; McMahon, E | 1 |
Check, JH; Cohen, R | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
Buzney, C; Buzney, E; Reynolds, RV; Sheu, J | 1 |
Bechtel, MA; Harfmann, KL | 1 |
Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
Ioannides, D; Lazaridou, E | 1 |
Vary, JC | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Chahal, DS; Hassoun, LA; Larsen, LN; Sivamani, RK | 1 |
Clark, AK; Quinonez, RL; Saric, S; Sivamani, RK | 1 |
Azarchi, S; Bienenfeld, A; Lo Sicco, K; Marchbein, S; Nagler, AR; Shapiro, J | 1 |
Freites-Martinez, A; Geer, EB; Goldfarb, S; Lacouture, ME; Rozner, RN; Shapiro, J | 1 |
Kyrgidis, A; Nikolakis, G; Zouboulis, CC | 1 |
Cadegiani, FA; Comeche, B; Gioia, F; Goren, A; Herrera, S; Kovacevic, M; McCoy, J; Ramos, PM; Ron, R; Serrano-Villar, S; Shapiro, J; Sinclair, R; Tosti, A; Vaño-Galván, S; Wambier, CG | 1 |
Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD | 1 |
Asrar, MM; Bashir, R; Ganie, MA; Shah, IA; Wani, IA | 1 |
Deoghare, S; Sadick, NS | 1 |
Hsiao, JL; Jeong, C; Masson, R; Shi, VY; Shih, T | 1 |
30 review(s) available for spironolactone and finasteride
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antiandrogen therapy in dermatology.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Cimetidine; Contraceptives, Oral; Cyproterone Acetate; Finasteride; Flutamide; Humans; Ketoconazole; Skin Diseases; Spironolactone | 1996 |
Hair regrowth. Therapeutic agents.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone | 1998 |
Hirsutes. II: Treatment.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Contraceptives, Oral; Cosmetics; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Hair Removal; Hirsutism; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Prednisolone; Spironolactone | 1998 |
Understanding and managing common baldness.
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome | 1999 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
Hirsutism: diagnosis and management.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Contraceptives, Oral; Eflornithine; Enzyme Inhibitors; Female; Finasteride; Hair; Hirsutism; Humans; Medical History Taking; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 2001 |
[Loss of hair].
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome | 2000 |
Hair loss remedies--separating fact from fiction.
Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents | 2004 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
A systematic review of commonly used medical treatments for hirsutism in women.
Topics: Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Spironolactone; Thiazolidinediones; Treatment Outcome | 2008 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Anti-androgen treatments.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone | 2010 |
Hirsutism: Diagnosis and management.
Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diagnosis, Differential; Eflornithine; Female; Finasteride; Hair Removal; Hirsutism; Humans; Hypoglycemic Agents; Laser Therapy; Metformin; Mineralocorticoid Receptor Antagonists; Neoplasms; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Spironolactone | 2010 |
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Contraceptives, Oral, Combined; Dermatology; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Life Style; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2014 |
Hair loss in women.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents | 2015 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.
Topics: Acetylcholine Release Inhibitors; Acne Vulgaris; Algorithms; Alopecia; Anti-Bacterial Agents; Antiperspirants; Benzoyl Peroxide; Botulinum Toxins; Contraceptives, Oral, Hormonal; Dermatologic Agents; Finasteride; Hair Follicle; Humans; Hyperhidrosis; Iontophoresis; Mandelic Acids; Minoxidil; Muscarinic Antagonists; Nails; Retinoids; Spironolactone; Sweat Glands; Sympathectomy | 2015 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
The use of hormonal agents in the treatment of acne.
Topics: Acne Vulgaris; Administration, Oral; Contraceptive Agents; Cortodoxone; Cyproterone Acetate; Dermatologic Agents; Female; Finasteride; Flutamide; Hormones; Humans; Male; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Propionates; Spironolactone; Treatment Outcome | 2016 |
Hormonal therapies for hidradenitis suppurativa: Review.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral, Hormonal; Dutasteride; Female; Finasteride; Hidradenitis Suppurativa; Hormones; Humans; Male; Spironolactone | 2017 |
Androgens in women: Hormone-modulating therapies for skin disease.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Alopecia; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dutasteride; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Receptors, Androgen; Spironolactone | 2019 |
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Finasteride; Hormone Antagonists; Humans; Spironolactone | 2019 |
Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data.
Topics: Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Finasteride; Hidradenitis Suppurativa; Humans; Metformin; Randomized Controlled Trials as Topic; Skin; Spironolactone; Treatment Outcome | 2019 |
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
Topics: Androgen Antagonists; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 2023 |
Combination therapy in female pattern hair loss.
Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Spironolactone; Treatment Outcome | 2023 |
Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
Topics: Finasteride; Flutamide; Hidradenitis Suppurativa; Humans; Liraglutide; Metformin; Spironolactone | 2023 |
6 trial(s) available for spironolactone and finasteride
Article | Year |
---|---|
A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
Topics: Adolescent; Adult; Female; Finasteride; Hair; Hirsutism; Hormones; Humans; Prospective Studies; Spironolactone; Treatment Outcome | 1995 |
Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
Topics: Adult; Drug Administration Schedule; Enzyme Inhibitors; Female; Finasteride; Gonadal Steroid Hormones; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies; Single-Blind Method; Spironolactone; Treatment Outcome | 1997 |
Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Biomarkers; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Humans; Prostate-Specific Antigen; Spironolactone; Testosterone | 2000 |
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Topics: Adult; Androgen Antagonists; Double-Blind Method; Female; Finasteride; Flutamide; Hair; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 2000 |
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Spironolactone; Testosterone | 2003 |
A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
Topics: Adult; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Sex Hormone-Binding Globulin; Spironolactone; Testosterone | 2004 |
15 other study(ies) available for spironolactone and finasteride
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Other antiandrogens.
Topics: Acne Vulgaris; Androgen Antagonists; Cimetidine; Female; Finasteride; Flutamide; Humans; Isotretinoin; Male; Spironolactone | 1998 |
Effects of different steroid-biosynthesis inhibitors on the testicular steroidogenesis of the toad Bufo arenarum.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgen Antagonists; Androgens; Animals; Bufonidae; Cholestenone 5 alpha-Reductase; Cyanoketone; Dehydroepiandrosterone; Enzyme Inhibitors; Finasteride; Male; Oxidoreductases; Pregnenolone; Spironolactone; Steroid 17-alpha-Hydroxylase; Testis; Testosterone | 2001 |
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
Topics: Alopecia; Diuretics; Enzyme Inhibitors; Female; Finasteride; Humans; Minoxidil; Spironolactone; United States; Vasodilator Agents | 2002 |
Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Spironolactone | 2002 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone | 2005 |
The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.
Topics: Animals; Animals, Newborn; Anticonvulsants; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Mineralocorticoid Receptor Antagonists; Pentylenetetrazole; Rats; Receptors, GABA; Receptors, Mineralocorticoid; Receptors, Progesterone; Seizures; Spironolactone | 2005 |
Prostate effect in dogs with the aldosterone receptor blocker eplerenone.
Topics: Animals; Atrophy; Dihydrotestosterone; Dogs; Eplerenone; Finasteride; Histocytochemistry; Male; Mineralocorticoid Receptor Antagonists; Organ Size; Prostate; Protein Binding; Receptors, Androgen; Spironolactone | 2013 |
Dihydrotestosterone may contribute to the development of migraine headaches.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; Finasteride; Humans; Migraine Disorders; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2013 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; COVID-19; Dutasteride; Finasteride; Humans; Intensive Care Units; Male; Middle Aged; Observational Studies as Topic; Patient Admission; Prospective Studies; SARS-CoV-2; Spironolactone | 2021 |
Female Pelvic Conditions: Polycystic Ovary Syndrome.
Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Infertility; Letrozole; Male; Obesity; Polycystic Ovary Syndrome; Spironolactone; Weight Loss | 2022 |